Table 1.
Notification ratesa per 100,000 population for chlamydia, gonorrhoea, and syphilis in countries of the WHO European region, 2019.
| Countries in the WHO European Regionb | Chlamydia | Gonorrhoea | Syphilis | Data source |
|---|---|---|---|---|
| EU/EEA Countries grouped by un geoscheme regionsd | ||||
| Northern Europe | ||||
| Denmark | 614.53 | 38.06 | 6.22 | SAID8 |
| Estonia | 80.31 | 5.89 | 2.79 | SAID |
| Finland | 293.24 | 10.96 | 4.55 | SAID |
| Iceland | 502.81 | 34.17 | 10.64 | SAID |
| Ireland | 182.72 | 57.32 | 15.19 | SAID |
| Latvia | 65.05 | 6.88 | 3.91 | SAID |
| Lithuania | 8.9 | 2 | 4.2 | SAID/LMH18 (syphilis) |
| Norway | 533.88 | 31.98 | 3.85 | SAID |
| Sweden | 340.01 | 31.72 | 4.21 | SAID |
| United Kingdom | 388.47 | 116.05 | 13.11 | SAID |
| Western Europe | ||||
| Austria | n/a | 18.03 | 6.53 | SA11 |
| Belgium | 72.01 | 22.89 | 14.51 | SAID |
| France | 35.40 | 5.61 | 1.68 | BSP19 (CT)/SAID |
| Germany | n/a | n/a | 9.55 | SAID |
| Luxemburg | 7.17 | 3.91 | 8.14 | SAID |
| Monacoc | n/a | n/a | n/a | n/a |
| Netherlands | 104.52 | 39.84 | 8.49 | SAID |
| Switzerlandc | 143.2 | 45.3 | 8.4 | OFSP12 |
| Southern Europe | ||||
| Andorrac | 12.3 | 8.6 | 2.5 | GA10 |
| Cyprus | 0.11 | 0.23 | 3.54 | SAID |
| Croatia | 3.68 | 0.98 | 0.69 | SAID |
| Greece | 0.58 | 1.87 | 4.13 | SAID |
| Italy | 1.85 | 1.36 | 3.05 | SAID |
| Malta | 64.84 | 32.62 | 19.25 | SAID |
| Portugal | 7.66 | 10.98 | 4.66 | SAID |
| San Marinoc | n/a | n/a | n/a | n/a |
| Slovenia | 19.08 | 10.72 | 2.6 | SAID |
| Spain | 38.54 | 21.79 | 10.4 | SAID |
| Eastern Europe | ||||
| Bulgaria | 1.73 | 0.31 | 6.86 | SAID |
| Czech Republic | n/a | 15.47 | 5.92 | SAID |
| Hungary | 9.34 | 13.97 | 8.06 | SAID |
| Poland | 1.1 | 0.74 | 4.28 | SAID |
| Romania | 0.07 | 0.17 | 2.78 | SAID |
| Slovakia | 14.31 | 6.77 | 5.1 | SAID |
| Non- EU/EEA Countries grouped by un geoscheme regionse | ||||
| Eastern Europe | ||||
| Belarus | 43.3 | 8.1 | 4.3 | Barbaric et al.9/NSCRB20 |
| Republic of Moldova | 71.7 | 25 | 54.2 | BSM13 |
| Russian Federation | n/a | 7.7 | 15 | FSSS14 |
| Ukraine | 31.6 | 7.4 | 5.7 | Barbaric et al./SSSU21/Krotik et al.22 |
| Southern Europe | ||||
| Albania | n/a | 0.3 | 2.4 | Barbaric et al. |
| Bosnia-Herzegovina | 3.6 | 0.3 | 0.8 | PIH16 |
| Montenegro | 3.05 | 0.48 | 0.32 | SOM17 |
| North Macedonia | 4.6 | 0.67 | 0.4 | Barbaric (CT, syphilis), SAID (NG) |
| Serbia | 10 | 1.54 | 2.3 | Barbaric (CT, syphilis), SAID (NG) |
| Central Asia | ||||
| Kazakhstan | 13.5 | 10.5 | 18.8 | Barbaric et al./BNS23 |
| Kyrgyzstan | 19.25 | 2.25 | 4.8 | ODPK15 |
| Tajikistan | n/a | 2.7 | 4 | Barbaric et al. |
| Turkmenistan | n/a | n/a | n/a | n/a |
| Uzbekistan | n/a | 10.7 | 8.7 | Barbaric et al. |
| Western Asia | ||||
| Armenia | 26.3 | 9.8 | 3.7 | Barbaric et al.9/SCRA24 |
| Azerbaijan | 19 | 3 | 8.2 | Barbaric et al./TSSCRA25 |
| Georgia | 39 | 18.5 | 26.5 | Barbaric et al./NSOG26 |
| Israel | 15.50 | 5.85 | 5.61 | MHI27 |
| Turkey | n/a | n/a | n/a | n/a |
Regarding the methods used to calculate notification rates, data for EU/EEA countries were extracted from the individual country notification rates in the ECDC Annual Epidemiological Reports for 2019,28, 29, 30 with a detailed description of the calculation methods available elsewhere.31 In short, the numerator comprises reported cases, while the denominator consists of population data obtained from Eurostat as of January 1st of each year. For non- EU/EEA countries our primary approach involved utilizing notification rates per 100,000 population as reported in the official national documents. In cases where this information was not available, we considered the absolute number of notified cases as the numerator, and the population of the respective year as the denominator.
The table includes data for 53 countries within the WHO European Region which were divided into two groups: the EU/EEA category and the non-EU/EEA category, and further categorized according to the United Nations geoscheme regions.
Countries that were part of the WHO European Region but were not in the EU/EEA region in 2019 (the UK was an EU member state in 2019). For the purpose of this review Switzerland and the European microstates—Andorra, Monaco, and San Marino—that are part of the WHO European Region but were not EU/EEA members in 2019 were allocated to their respective UN Geoscheme. Liechtenstein, an EEA member state, started to report to the European Surveillance system in 2020.
Data from 29 EU/EEA countries in 2019 were extracted from the Surveillance Atlas of Infectious Diseases (SAID),8 hosted by the European Centre for Disease Prevention and Control (ECDC). In addition to SAID, national statistical reports were utilized for CT in France (BSP)19 and for syphilis in Lithuania (LMH)18 Data for 3 countries: Andorra (GA),10 Austria (SA)11 and Switzerland (OFSP)12 were extracted from their respective national statistical reports. We could not find data for the years 2019 (or 2018) for 2 countries: Monaco and San Marino.
Data from 11 countries in the non- EU/EEA group were obtained from an assessment conducted by the WHO Regional Office for Europe (WHO/Europe), which included data extracted from the WHO Communicable Diseases Annual Reporting Forms (Babaric et al.)9 and complemented with national reports (NSCRB,20 SSSU,22 BNS,23 SCRA,24 TSSCRA25). The data corresponds to the year 2019, except for Albania, North Macedonia, Serbia and Tajikistan, which corresponds to the year 2018. Data from 6 other non- EU/EEA countries was obtained from national statistical reports, including notification rates for CT, NG and syphilis from Moldova (BSM),13 the Russian Federation (FSSS),14 Kyrgyzstan (ODPK),15 Bosnia-Herzegovina (PIH),16 Montenegro (SOM),17 and Israel (MHI)27 The data for Bosnia and Herzegovina are only from the Republic of Srpska. We could not find data for the years 2019 (or 2018) for 2 countries—Turkmenistan and Turkey. CT reports were not found or not reported in Albania, Austria, Germany, Czechia, the Russian Federation, Tajikistan and Uzbekistan. NG reports were not found for Germany.